Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 5, Mai 2002
Page(s) 542 - 543
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/2002185542
Publié en ligne 15 mai 2002
  1. Wu H, Liu X, Jaenish R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83 : 59–67.
  2. Bergrem H, Danielson BG, Eckardt KU, Kurtz A, Strisberg M. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In : Erythropoïetin: molecular physiology and clinical application. New York : Marcel Dekker, 1993 : 266–75.
  3. Peces R, de la Torre M, Alcazar R, Urra JM. Antibodies against recombinant human erythropoietin in a patient with ery-thropoietin-resistant anemia. N Engl J Med 1996; 335 : 524–5.
  4. Prabhakar S, Muhlfelder T. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 1997; 47 : 331–5.
  5. Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002 346 : 469–75.
  6. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Spontaneous auto-antibody against erythropoietin in a case of pure red cell aplasia. N Engl J Med 1996; 334 : 630–3.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.